A detailed history of Champlain Investment Partners, LLC transactions in Si Bone, Inc. stock. As of the latest transaction made, Champlain Investment Partners, LLC holds 2,441,252 shares of SIBN stock, worth $32 Million. This represents 0.2% of its overall portfolio holdings.

Number of Shares
2,441,252
Previous 2,453,147 0.48%
Holding current value
$32 Million
Previous $40.2 Million 21.4%
% of portfolio
0.2%
Previous 0.24%

Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

SELL
$11.93 - $16.34 $141,907 - $194,364
-11,895 Reduced 0.48%
2,441,252 $31.6 Million
Q1 2024

May 13, 2024

BUY
$15.15 - $21.58 $19 Million - $27.1 Million
1,255,610 Added 104.85%
2,453,147 $40.2 Million
Q4 2023

Feb 13, 2024

BUY
$15.75 - $21.38 $12.1 Million - $16.4 Million
765,290 Added 177.05%
1,197,537 $25.1 Million
Q3 2023

Nov 13, 2023

SELL
$20.22 - $27.36 $8.84 Million - $12 Million
-437,138 Reduced 50.28%
432,247 $9.18 Million
Q2 2023

Aug 11, 2023

SELL
$19.39 - $28.9 $16.2 Million - $24.2 Million
-836,815 Reduced 49.05%
869,385 $23.5 Million
Q1 2023

May 12, 2023

SELL
$12.71 - $21.17 $472,240 - $786,571
-37,155 Reduced 2.13%
1,706,200 $33.6 Million
Q4 2022

Feb 13, 2023

SELL
$11.23 - $19.44 $636,179 - $1.1 Million
-56,650 Reduced 3.15%
1,743,355 $23.7 Million
Q3 2022

Nov 14, 2022

SELL
$12.2 - $18.71 $223,870 - $343,328
-18,350 Reduced 1.01%
1,800,005 $31.4 Million
Q2 2022

Aug 12, 2022

SELL
$12.05 - $22.74 $646,241 - $1.22 Million
-53,630 Reduced 2.86%
1,818,355 $24 Million
Q1 2022

May 12, 2022

SELL
$18.32 - $23.03 $1.8 Million - $2.27 Million
-98,400 Reduced 4.99%
1,871,985 $42.3 Million
Q4 2021

Feb 10, 2022

BUY
$18.75 - $24.8 $36.9 Million - $48.9 Million
1,970,385 New
1,970,385 $43.8 Million

Others Institutions Holding SIBN

About SI-BONE, Inc.


  • Ticker SIBN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 34,305,000
  • Market Cap $450M
  • Description
  • SI-BONE, Inc., a medical device company, develops implantable devices used to solve musculoskeletal disorders of the sacropelvic anatomy in the United States and internationally. It offers iFuse, a minimally invasive surgical implant system to address sacroiliac joint dysfunction and degeneration, adult deformity, and pelvic ring traumatic fract...
More about SIBN
Track This Portfolio

Track Champlain Investment Partners, LLC Portfolio

Follow Champlain Investment Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Champlain Investment Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Champlain Investment Partners, LLC with notifications on news.